Innovative and accredited continuing medical education for today’s practicing clinicians.

CME Institute is trusted by physicians across medical specialties for premium continuing education that yields the highest educational outcomes. These ACCME-accredited activities make the latest research, novel therapies, and clinical best practices accessible and approachable for physician, NP, PA, and PharmD learners.

  • Expert-led insights to improve patient outcomes
  • Multi-modal courses to suit all learning styles
  • Timely topics for relevant application to practice
  • Razor-focused approach to innovation that includes documentary-style video and micro-learning Tweetorials
  • A commitment to collective mindfulness 

Bipolar Disorder Education Collection by CME Institute

Recent courses

  • Video
  • Self-study / Enduring
  • Major Depressive Disorder
  • Women’s Mental Health
Pharmacology for MDD is limited by low efficacy, delayed response, and side effects. Research on the pathophysiology of the disease that includes the glutamatergic system and GABA signaling is ushering in a new era for rapidly acting antidepressants.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Video
  • Self-study / Enduring
  • Major Depressive Disorder
  • Women’s Mental Health
The new fast-acting antidepressants esketamine, an NMDA receptor antagonist, and positive allosteric modulators of GABAergic neurotransmission brexanolone and zuranolone have created an important and exciting paradigm shift in the treatment of depression.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Video
  • Self-study / Enduring
  • Rett Syndrome
  • Child and Adolescent Psychiatry
  • Movement Disorders
  • Neurology
Because of the multiple comorbidities associated with Rett syndrome, clinicians are advised to incorporate clinical guidelines that suggest implementing therapeutics with a multidisciplinary approach and with an eye toward new and emerging therapies. 
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Tweetorial
  • Self-study / Enduring
  • Tardive Dyskinesia
In this Tweetorial learn the causes, signs and symptoms, assessments tools, and treatments for the medication-induced movement disorder tardive dyskinesia.
    • 0.25 AMA PRA Category 1 Credit™
    • 0.25 Participation
  • Self-study / Enduring
  • Video
  • Cardiology
  • Comorbidity
  • Education
  • Integrated Care
  • Medical Conditions
  • Pulmonary Disease
Pulmonary arterial hypertension requires risk stratification to develop goal-directed treatment plans, including combination therapy targeting multiple pathways.
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Journal
  • Self-study / Enduring
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
Among the most transformative Alzheimer Disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Journal
  • Self-study / Enduring
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Video
  • Self-study / Enduring
  • Renal Disease
  • Adherence
  • Cardiology
  • Comorbidity
  • Diagnostic Tools
  • Education
  • Medical Conditions
  • Primary Care
  • Side Effects
  • Weight
Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Journal
  • Self-study / Enduring
  • Wilson Disease
  • Genetics
Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen and the latest updates in the field.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Self-study / Enduring
  • Video
  • Movement Disorders
  • Psychotic Disorders
  • Side Effects
  • Tardive Dyskinesia
Clinicians should screen regularly for signs and symptoms of tardive dyskinesia and educate patients and caregivers on what to look for and report, leading to earlier intervention and better quality of life.
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Self-study / Enduring
  • Video
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Schizophrenia affects 1% of the world’s population largely during a patient’s most productive years. Multiple treatments are available, however many gaps to recovery exist. Learn from experts diagnostic criteria for and defining recovery in schizophrenia.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
  • Self-study / Enduring
  • Video
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder’s reward circuitry can help with intervention and patients’ leading more fulfilling lives.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation

Pages

My Courses

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.